ArticleJournal of diabetes science and technology2019

Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.

Johannes Pöhlmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.